CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 136 filers reported holding CATALYST PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $4,000 | +100.0% | 599 | +103.1% | 0.00% | – |
| Q1 2022 | $2,000 | -80.0% | 295 | -79.9% | 0.00% | – |
| Q4 2021 | $10,000 | -9.1% | 1,465 | -30.8% | 0.00% | – |
| Q3 2021 | $11,000 | -15.4% | 2,116 | -5.1% | 0.00% | – |
| Q2 2021 | $13,000 | +30.0% | 2,229 | +5.3% | 0.00% | – |
| Q1 2021 | $10,000 | – | 2,116 | +1566.1% | 0.00% | – |
| Q4 2020 | $0 | – | 127 | 0.0% | 0.00% | – |
| Q3 2020 | $0 | – | 127 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,378,584 | $3,116,000 | 2.30% |
| TANAKA CAPITAL MANAGEMENT INC | 147,993 | $298,000 | 0.90% |
| SOPHROSYNE CAPITAL LLC | 282,500 | $638,000 | 0.56% |
| Ghost Tree Capital, LLC | 200,000 | $452,000 | 0.27% |
| Orbimed Advisors | 1,895,000 | $4,283,000 | 0.05% |
| Financial Architects, Inc | 30,000 | $68,000 | 0.04% |
| Cowen Prime Services LLC | 43,550 | $98,000 | 0.04% |
| Rotella Capital Management, Inc. | 12,300 | $28,000 | 0.03% |
| FEDERATED HERMES, INC. | 3,267,000 | $7,384,000 | 0.02% |
| Baker Brothers Advisors | 569,853 | $1,288,000 | 0.02% |